Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 
Press Release
 View printer-friendly version << Back

The University of Pennsylvania, The Abramson Family Cancer Research Institute at the Abramson Cancer Center of UPenn, Craig Thompson, M.D., Agios Pharmaceuticals and Celgene Corporation Announce Resolution of Lawsuits

New York, New York, August 31, 2012 - The parties to the lawsuits captioned, The Leonard and Madlyn Abramson Family Cancer Research Institute at the Abramson Cancer Center of the University of Pennsylvania v. Craig Thompson, M.D., Agios Pharmaceuticals, Inc., and Celgene Corporation and Trustees of the University of Pennsylvania v. Craig Thompson, M.D., and Agios Pharmaceuticals, Inc., are pleased to announce that they have entered into an agreement that will result in the dismissal of both cases in their entirety.  The terms of the parties’ agreement are confidential.